Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients

Journal of Neuroimmunology

Volumn 254, Issue 1-2, 2013, Pages 170-173

  Karrenbauer, Virginija Danylaite ^a   Prejs, Robert ^b   Masterman, Thomas ^a   Hillert, Jan ^a   Glaser, Anna ^a   Imrell, Kerstin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

15; Cerebrospinal fluid; HLA DRB1; Immunoglobulin G; Magnetic resonance imaging; Multiple sclerosis; Oligoclonal bands

Indexed keywords

HLA DRB1 ANTIGEN; IMMUNOGLOBULIN; OLIGOCLONAL IMMUNOGLOBULIN G BAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN DAMAGE; CEREBROSPINAL FLUID LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC RISK; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN;

ADULT; ALLELES; BRAIN; FEMALE; FOLLOW-UP STUDIES; HLA-DRB1 CHAINS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84871710173     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.08.011     Document Type: Article

References (15)

1. Andersson M., Alvarez-Cermeno J., Bernardi G., Cogato I., Fredman P., Frederiksen J., Fredrikson S., Gallo P., Grimaldi L.M., Gronning M., et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry 1994, 57:897-902.
2. Calabrese M., De Stefano N., Atzori M., Bernardi V., Mattisi I., Barachino L., Morra A., Rinaldi L., Romualdi C., Perini P., Battistin L., Gallo P. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch. Neurol. 2007, 64:1416-1422.
3. Calabrese M., Federle L., Bernardi V., Rinaldi F., Favaretto A., Varagnolo M.C., Perini P., Plebani M., Gallo P. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Mult. Scler. 2012, 18:174-180.
4. Greer J.M., Csurhes P.A., Muller D.M., Pender M.P. Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis. J. Immunol. 2008, 180:6402-6410.
5. Huttner H.B., Schellinger P.D., Struffert T., Richter G., Engelhorn T., Bassemir T., Maurer M., Garcia M., Schwab S., Kohrmann M., Doerfler A. MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns. J. Neurol. 2009, 256:1121-1125.
6. Imrell K., Landtblom A.M., Hillert J., Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 2006, 67:1062-1064.
7. Imrell K., Greiner E., Hillert J., Masterman T. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis. J. Neuroimmunol. 2009, 210:128-130.
8. Kikuchi S., Fukazawa T., Niino M., Yabe I., Miyagishi R., Hamada T., Hashimoto S.A., Tashiro K. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology 2003, 60:647-651.
9. Lundkvist M., Greiner E., Hillert J., Fogdell-Hahn A. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta. Mult. Scler. 2010, 16:796-800.
10. Marrosu M.G., Murru M.R., Costa G., Murru R., Muntoni F., Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum. Mol. Genet. 1998, 7:1235-1237.
11. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
12. Olsson T., Kostulas V., Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin. Chem. 1984, 30:1246-1249.
13. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
14. Ziemann U., Wahl M., Hattingen E., Tumani H. Development of biomarkers for multiple sclerosis as a neurodegenerative disorder. Prog. Neurobiol. 2011, 95:670-685.
15. Zivadinov R., Uxa L., Bratina A., Bosco A., Srinivasaraghavan B., Minagar A., Ukmar M., Benedetto S., Zorzon M. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Int. Rev. Neurobiol. 2007, 79:521-535.